Results 261 to 270 of about 17,175,483 (375)
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
Efstathios Kastritis +13 more
openalex +2 more sources
CyBorD: stellar response rates in AL amyloidosis [PDF]
Giampaolo Merlini
openalex +1 more source
Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case report. [PDF]
Androulakis E +3 more
europepmc +1 more source
ABSTRACT Background Amyloidosis is a rare, multisystem disorder characterized by extracellular deposition of misfolded protein fibrils. Gastrointestinal (GI) amyloidosis is uncommon but under‐recognized due to nonspecific symptoms, but early diagnosis is critical to improve quality of life and prognosis.
Myo Jin Tang +3 more
wiley +1 more source
A Case of Renal Chromophobe Cell Carcinoma with Systemic AL Amyloidosis
Shoko Nakamura +7 more
openalex +2 more sources
Haemorrhage and amyloidosis ― response to Veneri et al [PDF]
C. Wettlé +2 more
openalex +1 more source
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis. [PDF]
Muchtar E +19 more
europepmc +1 more source
Abstract Cognitive assessment and analysis of plasma biomarkers are lower‐cost options for the early assessment of Alzheimer's disease (AD). In this study, we examined whether serial position markers in the Rey's AVLT were sensitive to plasma AD biomarkers in cognitively unimpaired older individuals.
Davide Bruno +6 more
wiley +1 more source
Therapy of AL amyloidosis – work-up and treatment at our centre [PDF]
Christoph Kimmich +4 more
openalex +1 more source

